Hypersen sitivity Systemic Reaction Following Intravesical Bacillus Calmette-Guerin: Successful Treatment With Steroids
Authors:
- 1 March 1992
- journal article
- case report
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 147 (3 Part 1) , 695-697
Abstract
Intravesical bacillus Calmette-Guerin (BCG) is an effective treatment for superficial bladder carcinoma. Serious complications, including disseminated BCG infection, are infrequent. We report a case of granulomatous hepatitis with pneumonitis following intravesical administration of BCG. Cultures for mycobacteria were negative in sputum, bronchoalveolar lavage, liver and blood specimens. All symptoms disappeared within days after steroid therapy. Hypersensitivity reaction should be considered in patients with systemic symptoms after immunotherapy with BCG.Keywords
This publication has 10 references indexed in Scilit:
- Hypersensitivity reaction to bacillus calmette-guérin treated with plasmapheresisThe American Journal of Medicine, 1989
- Toxicity of intravesical BCG and its management in patients with superficial bladder tumorsCancer, 1987
- Granulomatous Hepatitis Following Intravesical Bacillus Calmette-guerin Therapy for Bladder CarcinomaJournal of Urology, 1987
- Complications of Bacillus Calmette-Guerin Immunotherapy in 1,278 Patients with Bladder CancerJournal of Urology, 1986
- SYSTEMIC COMPLICATIONS OF INTRAVESICAL BCG THERAPY FOR BLADDER CANCERThe Lancet, 1985
- Long-Term Results and Complications of Intracavitary Bacillus Calmette-Guerin Therapy for Bladder CancerJournal of Urology, 1984
- Granulomatous hepatitis as a late complication of BCG immunotherapyCancer, 1980
- Bacillus Calmette-guerin Immunotherapy of Superficial Bladder CancerJournal of Urology, 1980
- Clinical and immunologic studies of disseminated BCG infectionCancer, 1978
- Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder TumorsJournal of Urology, 1976